Skip to main content
Springer Nature Link
Log in

Oxidant/antioxidant status in premenstrual syndrome

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To investigate oxidant/antioxidant status in premenstrual syndrome (PMS).

Methods

Study group (n = 20) consisted of PMS and control group (n = 21) consisted of normal menstruating women. The serum oxidant status was assessed by the lipid hydroperoxide (LHP), malondialdehyde (MDA) and protein carbonyl (PC); the antioxidant status was assessed by the total thiol (T-SH) and total antioxidant capacity (TAC).

Results

The study and control groups revealed no statistical difference, in terms of day 3 LHP, MDA, PC, T-SH and TAC levels. There were no significant differences between groups in terms of day 21 MDA, PC and T-SH levels. However, day 21 LHP levels were increased and TAC levels were decreased in the study group compared with the control group.

Conclusion

Increased oxidative stress and reduced antioxidant capacity may occur in PMS. It can be speculated that the imbalance of oxidant/antioxidant systems may be a cause or the consequence of the various stress symptoms in PMS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Freeman EW (2003) Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 28:25–37

    Article  PubMed  Google Scholar 

  2. Halbreich U (2004) The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder-clinical procedures and research perspectives. Gynecol Endocrinol 19:320–334

    Article  CAS  PubMed  Google Scholar 

  3. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C et al (2006) Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health 15:57–69

    Article  Google Scholar 

  4. Halbreich U, Borenstein J, Pearlstein T, Kahn LS (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 28:1–23

    CAS  Google Scholar 

  5. Alpay FB, Turhan NO (2001) Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders. Int J Fertil Womens Med 46:228–231

    CAS  PubMed  Google Scholar 

  6. Halbreich U (2003) The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 28:55–99

    Article  CAS  Google Scholar 

  7. Kendler KS, Karkowski LM, Corey LA, Neale MC (1998) Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 155:1234–1240

    CAS  PubMed  Google Scholar 

  8. Reame NE, Marshall JC, Kelch RP (1992) Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle. Psychoneuroendocrinology 17:205–213

    Article  CAS  PubMed  Google Scholar 

  9. Bäckström T, Andersson A, Andreé L, Birzniece V, Bixo M, Björn I et al (2003) Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci 1007:42–53

    Article  PubMed  Google Scholar 

  10. Evans MD, Dizdaroglu M, Cooke MS (2004) Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567:1–61

    Article  CAS  PubMed  Google Scholar 

  11. Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25:29–38

    Article  CAS  PubMed  Google Scholar 

  12. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R (2003) Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 8:365–370

    Article  CAS  PubMed  Google Scholar 

  13. Arranz L, Guayerbas N, De la Fuente M (2007) Impairment of several immune functions in anxious women. J Psychosom Res 62:1–8

    Article  PubMed  Google Scholar 

  14. Harma M, Harma M, Erel O (2005) Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 118:47–51

    Article  CAS  PubMed  Google Scholar 

  15. Harma M, Harma M, Kocyigit A (2004) Comparison of protein carbonyl and total plasma thiol concentrations in patients with complete hydatidiform mole with those in healthy pregnant women. Acta Obstet Gynecol Scand 83:857–860

    PubMed  Google Scholar 

  16. Lagod L, Paszkowski T, Sikorski R, Rola R (2001) The antioxidant prooxidant balance in pregnancy complicated by spontaneous abortion. Ginekol Pol 72:1073–1078

    CAS  PubMed  Google Scholar 

  17. Freemen E, Rickels K, Sondheimer SJ, Polansky M (1990) Ineffectiveness of progesteron suppository treatment for premenstrual syndrome. JAMA 264:349–353

    Article  Google Scholar 

  18. Zadeh-Nourooz J, Tajaddini-Sarmadi J, Wolff S (1994) Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220:403–409

    Article  Google Scholar 

  19. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358

    Article  CAS  PubMed  Google Scholar 

  20. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205

    Article  CAS  PubMed  Google Scholar 

  21. Benzie IF, Strain JJ (1999) Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Method Enzymol 299:15–27

    Article  CAS  Google Scholar 

  22. Korzekwa MI, Steiner M (1997) Premenstrual syndromes. Clin Obstet Gynecol 40:564–576

    Article  CAS  PubMed  Google Scholar 

  23. Kalia G, Sudheendran S, Rao A (2001) Antioxidant status and lipid peroxidation in premenstrual syndrome: a preliminary study. Clin Chim Acta 309:97–99

    Article  CAS  PubMed  Google Scholar 

  24. Balat O, Dikensoy E, Ugur MG, Atmaca R, Cekmen M, Yurekli M (2007) Malon dialdehyde, nitrite and adrenomedullin levels in patients with premenstrual syndrome. Arch Gynecol Obstet 275:361–365

    Article  CAS  PubMed  Google Scholar 

  25. Bäckström T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J (1983) Mood, sexuality, hormones, and the menstrual cycle II: hormone levels and their relationship to the premenstrual syndrome. Psychosom Med 45:503–507

    PubMed  Google Scholar 

  26. Halbreich U, Endicott J, Goldstein S, Nee J (1986) Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 74:576–586

    Article  CAS  PubMed  Google Scholar 

  27. Bremner JD, Innis RB, White T, Fujita M, Silbersweig D, Goddard AW et al (2000) SPECT [I-123] iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 47:96–106

    Article  CAS  PubMed  Google Scholar 

  28. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM (2003) Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 54:757–762

    Article  CAS  PubMed  Google Scholar 

  29. Rammal H, Bouayed J, Younos C, Soulimani R (2008) Evidence that oxidative stress is linked to anxiety-related behaviour in mice. Brain Behav Immun 22:1156–1159

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

I certify that no actual or potential conflict of interest in relation to this article exists.

Author information

Authors and Affiliations

  1. Department of Obstetric and Gynecology, University of Fatih, Hosdere Cad. No: 145, Yukari Ayranci, 06540, Ankara, Turkey

    Candan Iltemir Duvan, Nilgun Ozturk Turhan & Hasan Kafali

  2. Department of Biochemistry, University of Gazi, Ankara, Turkey

    Ahmet Cumaoglu

  3. Department of Pharmacology, University of Gazi, Ankara, Turkey

    Cimen Karasu

Authors
  1. Candan Iltemir Duvan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmet Cumaoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nilgun Ozturk Turhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cimen Karasu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hasan Kafali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Candan Iltemir Duvan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duvan, C.I., Cumaoglu, A., Turhan, N.O. et al. Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet 283, 299–304 (2011). https://doi.org/10.1007/s00404-009-1347-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-009-1347-y

Keywords

Search

Navigation